# Haploidentical Stem Cell Transplantation in Neuroblastoma

> **NCT00790413** · EARLY_PHASE1 · UNKNOWN · sponsor: **Lund University Hospital** · enrollment: 15 (estimated)

## Conditions studied

- Neuroblastoma

## Interventions

- **DRUG:** iodine I 131 metaiodobenzylguanidine
- **DRUG:** Fludarabine
- **DRUG:** Thiotepa
- **PROCEDURE:** T-cell depletion
- **PROCEDURE:** Haploidentical stem cell transplantation
- **PROCEDURE:** Donor Lymphocyte Infusion
- **DRUG:** Rituximab
- **PROCEDURE:** Co-transplantation of mesenchymal stem cells

## Key facts

- **NCT ID:** NCT00790413
- **Lead sponsor:** Lund University Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-08
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2021-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00790413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00790413, "Haploidentical Stem Cell Transplantation in Neuroblastoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00790413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*